91 reports of this reaction
1.8% of all RUFINAMIDE reports
#10 most reported adverse reaction
MULTIPLE DRUG RESISTANCE is the #10 most commonly reported adverse reaction for RUFINAMIDE, manufactured by Eisai Inc.. There are 91 FDA adverse event reports linking RUFINAMIDE to MULTIPLE DRUG RESISTANCE. This represents approximately 1.8% of all 5,100 adverse event reports for this drug.
Patients taking RUFINAMIDE who experience multiple drug resistance should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
MULTIPLE DRUG RESISTANCE is a less commonly reported adverse event for RUFINAMIDE, but still significant enough to appear in the safety profile.
In addition to multiple drug resistance, the following adverse reactions have been reported for RUFINAMIDE:
The following drugs have also been linked to multiple drug resistance in FDA adverse event reports:
MULTIPLE DRUG RESISTANCE has been reported as an adverse event in 91 FDA reports for RUFINAMIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
MULTIPLE DRUG RESISTANCE accounts for approximately 1.8% of all adverse event reports for RUFINAMIDE, making it a notable side effect.
If you experience multiple drug resistance while taking RUFINAMIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.